SmithKline Feosol recall
This article was originally published in The Tan Sheet
Executive Summary
Potential for Feosol Elixir Iron Supplement Therapy to crystallize inside plastic bottles, thereby reducing its strength, prompted SmithKline Beecham to initiate a recall of nearly 11,000 units distributed across the U.S. There have been no consumer complaints. While the distribution of the liquid in plastic bottles has been suspended, Feosol caplets and tablets will remain on the market. SmithKline switched from glass bottles last year. FDA has not yet classified the recall, filed in early February, but SB said the product does not present a health threat
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning